Category - Executive Moves

Executive Moves

Tempest appoints Drake Richey and Dr. John Yee to BoD

Tempest Therapeutics (NASDAQ: TPST) has appointed two independent directors, Drake Richey and John Yee, MD, MPH, to its board of directors (BoD), effective June 4, 2026. Mr. Richey and Dr. Yee collectively bring decades...

June 5, 2026

Executive Moves

Cocrystal appoints James Sapirstein as CEO

Cocrystal Pharma (NASDAQ: COCP) has appointed biopharma industry leader James Sapirstein as chief executive officer (CEO), effective immediately. According to Cocrystal, Mr. Sapirstein will also be appointed to its...

June 4, 2026

Executive Moves

Dr. John Lambert joins Defence BoD

Defence Therapeutics (CSE: DTC; OTCQB: DTCFF; FSE: DTC) has appointed Dr. John Lambert to its board of directors (BoD), effective immediately. Internationally recognized, Dr. Lambert brings more than four decades of...

June 1, 2026

Executive Moves

Former FDA official Peter J. Pitts joins BrainStorm BoD

BrainStorm Cell Therapeutics (OTCQB: BCLI) has appointed former FDA associate commissioner, Peter J. Pitts, to its board of directors (BoD), effective immediately. Mr. Pitts is a globally recognized expert in healthcare...

May 28, 2026

Executive Moves

Immunic appoints Michael W. Bonney as BoD chair

Immunic (NASDAQ: IMUX) has announced the appointment of biopharmaceutical executive Michael W. Bonney as chair of its board of directors (BoD), effective May 16, 2026. Simona Skerjanec, MPharm, MBA, will transition from...

May 19, 2026

Executive Moves

ARS appoints Donn Casale as president

ARS Pharmaceuticals (NASDAQ: SPRY) has appointed Donn Casale as president, effective June 1, 2026, with Richard Lowenthal continuing to lead as CEO. Mr. Casale brings 25 years of biopharmaceutical commercial leadership...

May 13, 2026

Executive Moves

BetterLife appoints Doug Drysdale as executive chairman and director

BetterLife Pharma (CSE: BETR; OTCQB: BETRF; FSE: NPAU) has appointed its current corporate advisor, Doug Drysdale, as executive chairman and director. Mr. Drysdale was formerly CEO of Cybin (NYSE: CYBN) where he led the...

May 13, 2026

Executive Moves

Dr. Kyle Bauser joins Titan Partners as Director, Senior Research Analyst

Investment bank Titan Partners has announced that Kyle Bauser, Ph.D., has been appointed Director, Senior Research Analyst covering healthcare technologies. Dr. Bauser brings more than 12 years of experience in equity...

May 12, 2026

Executive Moves

Lindsay Hamelin joins Restart’s BoD

Restart Life Sciences (CSE: HEAL; FSE: HN30; OTC Pink: NMLSF) has announced the appointment of capital markets veteran, Lindsay Hamelin, as an independent director on its board of directors (BoD), effective immediately...

May 7, 2026

Executive Moves

Nancy Saitta and Leilani Bradford join Planet 13’s BoD

Planet 13 Holdings (CSE: PLTH; OTCQX: PLNH) has announced the appointments of the Honorable Nancy Saitta and Leilani Bradford as independent directors, filling two newly created seats on its board of directors (BoD)...

May 5, 2026

Category - Executive Moves

Subscribe